PT  - JOURNAL ARTICLE
AU  - Cataldi, Devon
AU  - Bennett, Jonathan P.
AU  - Quon, Brandon K.
AU  - Leong, Lambert
AU  - Kelly, Thomas L
AU  - Evans, William J
AU  - Prado, Carla M.
AU  - Heymsfield, Steven B.
AU  - Shepherd, John A
TI  - Association of Muscle Strength to Body Composition Measures using DXA, D<sub>3</sub>Cr, and BIA in Collegiate Athletes
AID  - 10.1101/2023.05.17.23288849
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.05.17.23288849
4099  - http://medrxiv.org/content/early/2023/05/18/2023.05.17.23288849.short
4100  - http://medrxiv.org/content/early/2023/05/18/2023.05.17.23288849.full
AB  - Background Measurements of body composition are helpful indicators of health outcomes, but muscle strength has a greater correlation with disease risk and long-term health outcomes, particularly among older adults. Whole-body DXA scans uniquely parse out total and regional lean soft tissue (LST) and appendicular (ALST), primarily composed of skeletal muscle and often used to diagnose sarcopenia and frailty. An alternative approach measures the enrichment of deuterated Creatinine (D3Crn) in urine after ingesting a tracer dose of deuterated creatine (D3Cr) to determine creatine pool size and estimate whole-body muscle mass. The utility of D3Cr relationships between strength and body composition in young athletes has yet to be established. In this study, we investigated the association of muscle strength and body composition using multiple methods including DXA, D3Cr, and bioelectrical impedance (BIA), in a collegiate athletic population.Methods The Da Kine Study enrolled 80 multi-sport collegiate athletes. Each subject consumed a 60 mg dose of D3Cr and completed whole-body DXA, BIA, and strength tests of the leg and trunk using an isokinetic dynamometer. The analysis was stratified by sex. Pearson’s correlations, forward stepwise linear regression and quartile p trend significance were used to show the associations of body composition measures to muscle strength.Results The mean (SD) age of the 80 (40M/40F) athletes was 21.8 (4.2) years. Raw whole-body values had higher correlations with muscle strength in both sexes compared to the normalized values by height, body mass (BM), and BMI. DXA LST had the highest leg (R2=0.36, 0.37) and trunk (R2=0.53, 0.61) strength in both males and females. Trunk strength was more highly associated with body composition measures than leg strength in both sexes and all measurement techniques. One or more DXA LST measures (total, leg, and ALST) were consistently more highly associated with leg and trunk strengths for both sexes than BIA and D3Cr measures. Adjusting all body composition values by age, BMI, and BIA variables did not improve the associations. A significant p trend across quartiles was observed for DXA LST and ALST for all measures of strength in both sexes.Conclusion Although statistical significance was not reached between devices, DXA body composition output variables, especially LST, showed the highest associations with both sexes’ leg and trunk muscle strength. Furthermore, without adjustment for demographic information or BIA variables, whole-body values show stronger associations with muscle strength. Future research should investigate the impact of muscle mass changes on LST and functional measures.Competing Interest StatementJS received an investigator-initiated grant from TK at Hologic, Inc. to fund the larger study and also has received other grants on body composition from Hologic and GE Healthcare. SBH is on the Medical Advisory Board for Tanita Corporation. CMP reports receiving honoraria and/or paid consultancy from Abbott Nutrition, Nutricia, Nestle Health Science, Pfizer, and AMRA medical. All other authors report no conflicts of interest. Data described in the manuscript, codebook, and analytic code will be made available upon request pending an application and approval, payment, and or other.Funding StatementHologic Inc. [grant numbers 081018, 2018] supported this workAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Hawaii Research Compliance and Institutional Review Board (IRB), Protocol # 2018-01102I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors https://shepherdresearchlab.org/